Garrison, Z.; Clister, T.; Bleem, E.; Berry, E.G.; Kulkarni, R.P.
Comparison of Immunotherapy versus Targeted Therapy Effectiveness in BRAF-Mutant Melanoma Patients and Use of cGAS Expression and Aneuploidy as Potential Prognostic Biomarkers. Cancers 2024, 16, 1027.
https://doi.org/10.3390/cancers16051027
AMA Style
Garrison Z, Clister T, Bleem E, Berry EG, Kulkarni RP.
Comparison of Immunotherapy versus Targeted Therapy Effectiveness in BRAF-Mutant Melanoma Patients and Use of cGAS Expression and Aneuploidy as Potential Prognostic Biomarkers. Cancers. 2024; 16(5):1027.
https://doi.org/10.3390/cancers16051027
Chicago/Turabian Style
Garrison, Zachary, Terri Clister, Eric Bleem, Elizabeth G. Berry, and Rajan P. Kulkarni.
2024. "Comparison of Immunotherapy versus Targeted Therapy Effectiveness in BRAF-Mutant Melanoma Patients and Use of cGAS Expression and Aneuploidy as Potential Prognostic Biomarkers" Cancers 16, no. 5: 1027.
https://doi.org/10.3390/cancers16051027
APA Style
Garrison, Z., Clister, T., Bleem, E., Berry, E. G., & Kulkarni, R. P.
(2024). Comparison of Immunotherapy versus Targeted Therapy Effectiveness in BRAF-Mutant Melanoma Patients and Use of cGAS Expression and Aneuploidy as Potential Prognostic Biomarkers. Cancers, 16(5), 1027.
https://doi.org/10.3390/cancers16051027
